相关实验视频

Updated: Jun 21, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

多个生物库的门德尔随机化分析确定了低密度脂蛋白降低血胆固醇和胆结石疾病的相反途径

Guoyi Yang^1,2, Amy M Mason^3,4, Dipender Gill⁵

¹School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China. yanggy@connect.hku.hk.

European journal of epidemiology

|July 15, 2024

概括

降低低密度脂蛋白 (LDL) 胆固醇的不同方法对胆结石疾病风险有相反的影响. 类固醇可以降低风险,而PCSK9抑制剂和阿波蛋白B向可能会增加风险.

科学领域:

遗传学和心血管疾病流行病学
代谢疾病研究研究

背景情况:

高血低密度脂蛋白 (LDL) 胆固醇是冠状动脉疾病的已知危险因素.
胆汁胆固醇的积累是胆结石形成的主要驱动因素.
各种降低LDL胆固醇的策略对胆结石疾病风险的影响尚不清楚.

研究的目的:

使用孟德尔随机化研究不同血LDL胆固醇降低途径对胆结石疾病风险的独特影响.
确定将血LDL胆固醇与胆结石形成联系起来的特定遗传机制.

主要方法:

一个大规模的门德尔随机化 (MR) 研究,利用来自英国生物银行,FinnGen和日本生物银行的数据.
药物向MR分析与局部化评估LDL胆固醇降低疗法的影响.
聚类MR和途径分析,以探索潜在的机制并确定不同的遗传关联.

主要成果:

模仿他类药物使用的遗传变异与胆结石疾病风险降低有关 (OR 0.72).
模仿PCSK9抑制剂和准阿波利波蛋白B的基因变异与胆结石疾病风险增加有关 (分别为ORs 1.11和1.23).
途径分析显示,减少胆结石风险 (糖脂生物合成) 与增加风险 (脂蛋白代谢,ABC载体) 之间存在明显的遗传关联.

结论:

降低血LDL胆固醇的不同途径对胆结石疾病风险产生相反的影响.
像他类途径似乎对胆结石有保护作用,而PCSK9抑制和阿波利波蛋白B向可能会增加风险.
这些发现强调了在预防胆结石疾病的背景下考虑特定的降脂机制的重要性.

关键词:

集群的孟德尔随机化.药物目标门德尔式随机化胆结石病是一种胆结石病.这就是LDL胆固醇.

更多相关视频

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

相关概念视频

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...